Table 1.
CTC positive rate (CTC number > 0) in different malignancies.
| Cancer subtypes | Number of patients | Positivity of CTCs (%) |
|||
|---|---|---|---|---|---|
| Overall | triploid | tetraploid | polyploid | ||
| Liver Cancer | 126 | 107(84.9%) | 81 (65.4%) | 43 (40.2%) | 75(70.1%) |
| Lung Cancer | 85 | 79 (92.9%) | 63 (79.7%) | 36 (45.6%) | 56 (70.9%) |
| Colorectal Cancer | 39 | 33 (84.6%) | 26 (78.8%) | 17 (51.5%) | 21 (63.6%) |
| Renal Cancer | 74 | 68 (91.9%) | 48 (70.6%) | 28 (41.2%) | 51 (75%) |
| Breast Cancer | 38 | 36 (94.7%) | 26 (72.2%) | 15 (41.7%) | 24 (66.7%) |
| Bladder Cancer | 28 | 26(92.9%) | 20 (76.9%) | 15 (57.7%) | 16 (61.5%) |
| Gastric Cancer | 45 | 43 (95.6%) | 37 (86.0%) | 13 (30.2%) | 24 (55.8%) |
| Esophagus Cancer | 12 | 11 (91.7%) | 6 (54.5%) | 5 (45.5%) | 8 (72.7%) |
| Ovarian Cancer | 14 | 13 (92.9%) | 7 (53.8%) | 5 (38.5%) | 11 (84.6%) |
| Pancreatic Cancer | 12 | 11 (91.7%) | 10 (90.9%) | 10 (90.9%) | 5 (45.5%) |
| Others | 91 | 79 (87.0%) | 59 (74.7%) | 37 (46.8%) | 56 (70.9%) |